Patent ID: 11932646
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 0:
1. A compound of formula VII, or pharmaceutically acceptable salt thereof,, wherein
R1 is selected from a substituted C1-6alkyl, —C(O)Rx, (CH2)nC(O)Rx, (CH2)nC(O)ORx, (CH2)nC(O)NRxRx, or —(CH2)nC(O)NRxRxS(O)2Rx;
Rx, for each occurrence, is independently H, an optionally substituted C1-6alkyl, an optionally substituted C3-12cycloalkyl, an optionally substituted C3-12heterocycloalkyl, an optionally substituted C3-12aryl, an optionally substituted C3-12heteroaryl, NHNHR2, or C(NH)NH2;
R2 is H or C1-4 alkyl; and
each n is independently 0, 1 or 2,
wherein the substituted C1-6alkyl is not ethyl.